Skip to content

Ipratropium

Ipratropium (Atrovent) is an inhaled anticholinergic bronchodilator used for airway narrowing in chronic obstructive pulmonary disease. This catalogue lists Atrovent and Combimist L Inhaler, two inhaled medicines containing ipratropium.

Atrovent

Bronchospasm

20mcg

Ipratropium inhaler for bronchospasm and chronic obstructive pulmonary disease. It is a maintenance therapy, not a quick-relief inhaler.

From$15.60/ inhalerView

Combimist L Inhaler

Bronchospasm, Asthma

50mcg + 20mcg

A levosalbutamol and ipratropium inhaler for bronchospasm and asthma. It contains two bronchodilators, opening the airways through two different pathways.

From$42.33/ inhalerView

Key points

  • Ipratropium is available as an aerosol inhaler and nebulised solution, while the products listed here are inhalers.
  • Its COPD maintenance role means it is not the only response to sudden severe symptoms.
  • Atrovent is a single-ingredient inhaler containing ipratropium.

Brands and forms in this catalogue

Atrovent is the 20 microgram single-ingredient inhaler. Combimist L Inhaler lists 50 micrograms levosalbutamol plus 20 micrograms ipratropium. Both are inhalers in Respiratory Health, with Combimist L combining an anticholinergic bronchodilator with another bronchodilator ingredient.

Further reading